12:00 AM
Dec 16, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Chromosomal microarray analysis regulatory update

The American College of Obstetricians and Gynecologists recommended chromosomal microarray analysis (CMA) as the first-line genetic test in pregnancies showing fetal abnormalities by ultrasound. The physician group also recommended CMA as the preferred genetic test to help identify the...

Read the full 171 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >